Accessibility Skip to Global Navigation Skip to Local Navigation Skip to Content Skip to Search Skip to Site Map Menu

Pathology & Biochemistry Special Seminar

Associate Professor Rakesh Veedu

Center for Molecular Medicine and Innovative Therapeutics, Murdoch University, and Perron Institute for Neurological and Translational Science, Perth, Australia

Precision Nucleic Acids: Beginning of an Era of Gene-Targeting Therapies

Human genome sequencing has been a major milestone which significantly contributed towards the development of precision nucleic acid therapeutics to correct or regulate the expression of disease-causing genetic hallmarks. Various nucleic acid therapeutics approaches with different mechanisms of action including antisense oligonucleotides (ASOs), siRNAs, microRNA mimics, antimiRs, DNAzymes, aptamers and triplex-forming oligonucleotides have been developed over the years. Of these, ASO technology remains the most prominent and successful therapeutic strategy with eight ASO-based drugs approved for clinical use so far. Our research is focused on developing novel precision nucleic acid therapeutics and covers three core areas: nucleic acid synthesis, therapeutic & diagnostic development and nucleic acid drug delivery. My talk will provide an overview about our recent activities and the impact of oligonucleotide therapeutics for patient benefits.

A/Prof Veedu was an invited speaker at the recent Nucleic Acid Chemical Biology workshop at Massey University, and his visit to Dunedin is supported by the Departments of Pathology & Biochemistry.

Date Wednesday, 11 March 2020
Time 12:00pm - 1:00pm
Audience All University
Event Category Health Sciences
Event Type Seminar
CampusDunedin
DepartmentBiochemistry, Pathology (Dunedin)
LocationD’Ath Lecture Theatre, Department of Pathology

Save this event